Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 899376 | ISIN: US5147661046 | Ticker-Symbol: LDE
Frankfurt
24.01.25
08:01 Uhr
5,800 Euro
-0,250
-4,13 %
1-Jahres-Chart
LIFECORE BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
LIFECORE BIOMEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
5,9506,10020:35
5,9506,10020:29

Aktuelle News zur LIFECORE BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
LIFECORE BIOMEDICAL Aktie jetzt für 0€ handeln
17.01.Lifecore Biomedical, Inc.: Lifecore Biomedical Announces Special Stockholder Meeting2
17.01.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report-
07.01.Lifecore Biomedical to sell multi-purpose 10-head isolator filler1
07.01.Lifecore Biomedical Sells Excess Capital Equipment for $17M1
07.01.Lifecore Biomedical, Inc.: Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million103Company Believes it is Well Positioned for Mid-Term and Long-Term Growth asCurrent Capacity Continues to Support up to $300 Million in Annual Revenue CHASKA, Minn., Jan. 07, 2025 (GLOBE NEWSWIRE)...
► Artikel lesen
03.01.US Stocks Poised To Open Higher As Futures Advance: Tesla, Bumble, Lifecore Bio In Focus6
02.01.Lifecore Biomedical (NASDAQ:LFCR) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS1
02.01.Lifecore Biomedical GAAP EPS of -$0.25 beats by $0.04, revenue of $32.56M beats by $2.81M2
02.01.Lifecore Biomedical Earnings Report: Q2 Overview2
02.01.LIFECORE BIOMEDICAL, INC. \DE\ - 10-Q, Quarterly Report-
02.01.Lifecore Biomedical, Inc.: Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update103-- Recorded Revenues of $32.6 Million for Q2 Fiscal 2025 -- -- Signed Multiple Development Agreements with New Customers -- -- Strengthened Balance Sheet with Financing Raising Approximately $24.3...
► Artikel lesen
02.01.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report-
19.12.24Lifecore Biomedical, Inc.: Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 20251
19.12.24Lifecore Biomedical to Provide CDMO Services to Nirsum Labs1
19.12.24Lifecore unterstützt Nirsums Phase-2-Studie für Opioid-Behandlung1
19.12.24Lifecore to support Nirsum's phase 2 opioid treatment trial1
19.12.24Lifecore Biomedical, Inc.: Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment1
12.12.24Here's Why Arquitos Capital Management Largely Exited Lifecore (LFCR)1
26.11.24Lifecore extends credit terms, simplifies interest rates1
26.11.24Lifecore Biomedical, Inc.: Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO2
Seite:  Weiter >>
76 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1